Idiopathic Dilated Cardiomyopathy Cellular and Molecular Mechanisms, Clinical Consequences

Bibliographic Details
Other Authors: Figulla, Hans-Reiner (Editor), Kandolf, Reinhard (Editor), McManus, Bruce (Editor)
Format: eBook
Language:English
Published: Berlin, Heidelberg Springer Berlin Heidelberg 1993, 1993
Edition:1st ed. 1993
Subjects:
Online Access:
Collection: Springer Book Archives -2004 - Collection details see MPG.ReNa
LEADER 04517nmm a2200337 u 4500
001 EB000674098
003 EBX01000000000000000527180
005 00000000000000.0
007 cr|||||||||||||||||||||
008 140122 ||| eng
020 |a 9783642778919 
100 1 |a Figulla, Hans-Reiner  |e [editor] 
245 0 0 |a Idiopathic Dilated Cardiomyopathy  |h Elektronische Ressource  |b Cellular and Molecular Mechanisms, Clinical Consequences  |c edited by Hans-Reiner Figulla, Reinhard Kandolf, Bruce McManus 
250 |a 1st ed. 1993 
260 |a Berlin, Heidelberg  |b Springer Berlin Heidelberg  |c 1993, 1993 
300 |a XVI, 405 p. 5 illus. in color  |b online resource 
505 0 |a I. Introductory Perspectives -- Idiopathic Dilated Cardiomyopathy: Current Concepts in Clinical Research -- II. Epidemiology and Natural Course of IDC -- Epidemiology of Idiopathic Dilated Cardiomyopathy -- Natural History of Idiopathic Dilated Cardiomyopathy -- III. Basic Molecular Concepts Toward Understanding of IDC -- Molecular Analysis of Cardiac Growth and Development in Transgenic Mouse Model Systems -- The Promoter of the Human Cardiac ?-Myosin Heavy-Chain Gene Is Controlled by an Upstream Enhancer -- Growth Factor Expression in the Cardiac Myocyte -- IV. Structural Abnormalities in IDC -- The Cytoskeleton and Extracellular Matrix in Human Hearts with Dilated Cardiomyopathy -- Macro- and Micropathology of Dilated Cardiomyopathy -- Detection of Disruption of Sarcolemmal Membrane by Indium-111 Labeled Antimyosin Antibody Scan -- Extracellular Matrix Expression, Organization, and Interaction with Heart Myocytes During Development and Disease -- V. Contraction and Relaxation --  
505 0 |a Na+ Channels as Molecular Substrate of Cardiac Excitability: Elementary Properties and Responsiveness to Drugs -- The Involvement of Gs in Regulation of the L-Type Voltage-Gated Ca2+ Channel -- Inositol Phosphates in Cardiac Regulation -- VIII. Virus and Cardiomyopathy -- Enterovirus-Induced Cardiomyopathy: Molecular Analysis of Acute and Persistent Myocardial Infections -- Direct Damage of Myocardium by Enterovirus -- Natural History of Enterovirus Persistence in the Murine Model of Coxsackievirus-Induced Myocarditis: A Quantitative In Situ Hybridization and Immunohistochemistry Study -- Detection and Typing of Enteroviruses -- Specific and Nonspecific Heart Defenses in Enteroviral Infections -- IX. Immunological Factors in Cardiomyopathy -- Heart Autoantibodies in Human Myocarditis and Cardiomyopathy: Virus and Skeletal Muscle Cross-reactivity -- Are Anti-cardiac Antibodies in Dilated Cardiomyopathy “Natural” Antibodies? -- X. Therapeutic Options in IDC and Myocarditis --  
505 0 |a Animal Models for Therapeutic Trials of Viral Myocarditis -- Immunosuppressive Therapy in Human Myocarditis -- Interferon Therapy in Enterovirus-Associated Idiopathic Dilated Cardiomyopathy -- The Role of ?-Blockers in Idiopathic Dilated Cardiomyopathy: Clinical Effect and Molecular Mechanism -- The Role of Calcium Channel Blockers in Idiopathic Dilated Cardiomyopathy -- Gene Therapy for Cardiovascular Disease: Realistic Possibilities for the Future 
505 0 |a Ventricular Remodeling in Idiopathic Dilated Cardiomyopathies -- Mechanisms of Deficient cAMP Generation in Heart Failure -- Abnormal Calcium Metabolism in Heart Muscle Dysfunction -- Energy Requirements of Contraction and Relaxation of the Heart -- VI. Microcirculation and Oxygen Supply in Cardiac Hypertrophy and IDC -- Capillary Density, Distribution, and Length Parameters Related to Oxygen Supply in Myocardial Hypertrophy and Atrophy -- Microcirculation in the Cardiomyopathic Syrian Hamster and in Human Congestive Cardiomyopathy -- The Microcirculation in Cardiac Hypertrophy -- Myocardial Oxygen Consumption in Patients with Idiopathic Dilated Cardiomyopathy: Effects of Vasodilating and Inotropic Agents -- Regression of Cardiac Hypertrophy with Pharmacotherapeutic Regimen -- VII. Ionic Channels and Signal Gating.-?-Adrenergic Receptor Dysfunction in the Pathogenesis of Idiopathic Dilated Cardiomyopathy --  
653 |a Human physiology 
653 |a Cardiology 
653 |a Biochemistry 
653 |a Human Physiology 
700 1 |a Kandolf, Reinhard  |e [editor] 
700 1 |a McManus, Bruce  |e [editor] 
041 0 7 |a eng  |2 ISO 639-2 
989 |b SBA  |a Springer Book Archives -2004 
028 5 0 |a 10.1007/978-3-642-77891-9 
856 4 0 |u https://doi.org/10.1007/978-3-642-77891-9?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 616.12